<html>
<head>
<title>Section 126-A:70 Definitions. </title>
<!-- Hide metadata
<titlename>TITLE X PUBLIC HEALTH</titlename>
<chapter>CHAPTER 126-A DEPARTMENT OF HEALTH AND HUMAN SERVICES</chapter>
<sectiontitle>Section 126-A:70 Definitions. </sectiontitle>
-->
</head>
<body>
<center><h1>TITLE X<br>PUBLIC HEALTH</h1></center>
<center><h2>CHAPTER 126-A<br>DEPARTMENT OF HEALTH AND HUMAN SERVICES</h2></center>
<center><h2>Administration of Epinephrine</h2></center>
<center><h3>Section 126-A:70</h3></center>
&nbsp;&nbsp;&nbsp;<b> 126-A:70 Definitions.  &#150;</b>
<codesect>
In this subdivision:
<br>
&nbsp&nbsp&nbsp
I. "Administer'' means the direct application of an epinephrine auto-injector to the body of an individual.
<br>
&nbsp&nbsp&nbsp
II. "Authorized entity'' means any entity or organization in which allergens capable of causing anaphylaxis may be present, including recreation camps and day care facilities.  Authorized entity shall not include an elementary or secondary school or a postsecondary educational institution eligible to establish policies and guidelines for the emergency administration of epinephrine under RSA 200-N.
<br>
&nbsp&nbsp&nbsp
III. "Epinephrine auto-injector'' means a single-use device used for the automatic injection of a premeasured dose of epinephrine into the human body.
<br>
&nbsp&nbsp&nbsp
IV. "Health care practitioner'' means a person who is lawfully entitled to prescribe, administer, dispense, or distribute controlled drugs.
<br>
&nbsp&nbsp&nbsp
V. "Provide'' means to furnish one or more epinephrine auto-injectors to an individual.
</codesect>
<sourcenote>
<p><b>Source.</b>  2016, 39:1, eff. July 2, 2016.</p>
</sourcenote>
</body>
</html>
